Selective anticancer drugs

被引：0
|
作者：
Joshua H. Atkins
Leland J. Gershell
机构：
[1] Managing Partners at AGW BioStrategy,
来源：
Nature Reviews Drug Discovery | 2002年 / 1卷 / 7期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：491 / 492
页数：1
相关论文
共 50 条
  • [41] SELECTIVE CONCENTRATION IN LIVER AND THORACIC DUCT LYMPH OF ANTICANCER DRUGS BY HEPATIC OUTFLOW BLOCK
    GROSSI, CE
    ROUSSELOT, LM
    GONZALEZ, EM
    CONTE, AJ
    AMERICAN JOURNAL OF SURGERY, 1966, 111 (01): : 59 - +
  • [42] Anticancer drugs Osmium offers anticancer hope
    Turley, Andrew
    CHEMISTRY & INDUSTRY, 2009, (01) : 6 - 6
  • [43] Drugs by Numbers: Reaction-Driven De Novo Design of Potent and Selective Anticancer Leads
    Spaenkuch, Birgit
    Keppner, Sarah
    Lange, Lisa
    Rodrigues, Tiago
    Zettl, Heiko
    Koch, Christian P.
    Reutlinger, Michael
    Hartenfeller, Markus
    Schneider, Petra
    Schneider, Gisbert
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (17) : 4676 - 4681
  • [44] Synthesis and anticancer activities of porphyrin induced anticancer drugs
    Dong Hong Li a Jun Lin Diao Ke Gui Yu Cheng He Zhou a State Key Laboratory of Trauma
    ChineseChemicalLetters, 2007, (11) : 1331 - 1334
  • [45] Synthesis and anticancer activities of porphyrin induced anticancer drugs
    Li, Dong Hong
    Diao, Jun Lin
    Yu, Ke Gui
    Zhou, Cheng He
    CHINESE CHEMICAL LETTERS, 2007, 18 (11) : 1331 - 1334
  • [46] Analysis of Anticancer Drugs in Sewage Water By Selective SPE and UPLC-ESI-MS-MS
    Yin, Jie
    Yang, Yi
    Li, Keji
    Zhang, Jing
    Shao, Bing
    JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2010, 48 (10) : 781 - 789
  • [47] 3 ALKALOIDS AS SELECTIVE DESTROYERS OF CANCER-CELLS IN MICE - SYNERGY WITH CLASSIC ANTICANCER DRUGS
    BELJANSKI, M
    BELJANSKI, MS
    ONCOLOGY, 1986, 43 (03) : 198 - 203
  • [48] Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs
    Kai Yuan
    Xiao Wang
    Haojie Dong
    Wenjian Min
    Haiping Hao
    Peng Yang
    Acta Pharmaceutica Sinica B, 2021, 11 (01) : 30 - 54
  • [49] Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs
    Yuan, Kai
    Wang, Xiao
    Dong, Haojie
    Min, Wenjian
    Hao, Haiping
    Yang, Peng
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (01) : 30 - 54
  • [50] Reversible tolerance to anticancer drugs
    Settleman, Jeffrey E.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
12345